Financials
Income statement
| Fiscal date | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
|---|---|---|---|---|
| Total reported revenue | 44.6T | 42.0T | 37.5T | 33.5T |
| Cost of revenue | 12.3T | 16.6T | 10.1T | 8.5T |
| Gross profit | 32.3T | 25.4T | 27.4T | 25.0T |
| Operating expense | ||||
| Research & development | 4.1T | 3.8T | 3.5T | 3.2T |
| Selling general and admin | 1.1T | 993.1B | 930.2B | 855.7B |
| Other operating expenses | — | — | — | — |
| Operating income | 27.1T | 20.6T | 22.9T | 20.9T |
| Non operating interest income | ||||
| Income | 564.8B | 491.3B | 487.5B | 450.3B |
| Expense | 59.1B | 60.1B | 58.2B | 58.2B |
| Other income expense | 2.1T | -171.7B | 699.3B | 34.3B |
| Pretax income | 29.8T | 20.9T | 24.1T | 21.3T |
| Tax provision | 4.6T | 3.0T | 3.0T | 2.9T |
| Net income | 25.2T | 17.9T | 21.1T | 18.4T |
| Basic EPS | 1.1 | 0.8 | 0.9 | 0.8 |
| Diluted EPS | 1.1 | 0.8 | 0.9 | 0.8 |
| Basic average shares | 23.2T | 23.3T | 23.4T | 23.4T |
| Diluted average shares | 23.4T | 23.5T | 23.6T | 23.6T |
| EBITDA | 30.5T | 21.5T | 24.6T | 21.8T |
| Net income from continuing op. | 25.2T | 17.9T | 21.1T | 18.4T |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |